# Metabolic Profile and Anthropometric Changes in Schizophrenia

> **NCT00534183** · NA · COMPLETED · sponsor: **Central Institute of Psychiatry, Ranchi, India** · enrollment: 2006 (actual)

## Conditions studied

- Metabolic Syndrome
- Diabetes
- Obesity

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** Risperidone
- **DRUG:** Haloperidol

## Key facts

- **NCT ID:** NCT00534183
- **Lead sponsor:** Central Institute of Psychiatry, Ranchi, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 2006 (ACTUAL)
- **Last updated:** 2007-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00534183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00534183, "Metabolic Profile and Anthropometric Changes in Schizophrenia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00534183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*